Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years-Reference-Cited by-同舟云学术

Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years

Published:2013-08-29 Issue:2 Volume:16 Page:124-136
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Wilding J. P. H.¹,Woo V.²,Rohwedder K.³,Sugg J.⁴,Parikh S.⁴,

Affiliation:

1. Diabetes and Endocrinology Research Group, Department of Obesity & Endocrinology; Clinical Sciences Centre, University Hospital Aintree; Liverpool UK

2. Section of Endocrinology and Metabolism, University of Manitoba; Winnipeg Canada

3. Clinical Development, AstraZeneca; Wedel Germany

4. Clinical Development, AstraZeneca; Wilmington DE USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12187/fullpdf

Reference42 articles.

1. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus;DeFronzo;Diabetes,2009

2. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study;Alvarez Guisasola;Diabetes Obes Metab,2008

3. Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care;Cook;Diabet Med,2007

4. Is glycemic control improving in U.S. adults?;Hoerger;Diabetes Care,2008

5. The impact of weight gain on motivation, compliance, and metabolic control in patients with type 2 diabetes mellitus;Pi-Sunyer;Postgrad Med,2009

Cited by 237 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A meta‐analysis of randomized controlled studies examining the effects of sodium‐glucose co‐transporter‐2 inhibitors on peripheral artery disease and risk of amputations;Diabetes, Obesity and Metabolism;2024-09-12

2. First-time Usage of SGLT2 Inhibitors in Patients with Type 2 Diabetes Who Are Fasting Ramadan: Efficacy and Safety;2024-08-06

3. Influence of Dapagliflozin Dosing on Low‐Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus: A Systematic Literature Review and Meta‐Analysis;The Journal of Clinical Pharmacology;2024-08

4. Supplementation with Highly Standardized Cranberry Extract Phytosome Achieved the Modulation of Urinary Tract Infection Episodes in Diabetic Postmenopausal Women Taking SGLT-2 Inhibitors: A RCT Study;Nutrients;2024-07-02

5. Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes;Cochrane Database of Systematic Reviews;2024-05-21